Log in to your Inderes Free account to see all free content on this page.

BICO Group

38.72

SEK

+3.92 %

Less than 1K followers

BICO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview

Ownership

Investor consensus

+3.92%

+0.78%

+17.4%

+20.92%

-1.97%

-18.86%

-77.36%

-65.55%

+184.18%

BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.

Market cap

2.73B SEK

Turnover

6.16M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Financial calendar

29.4.

2025

Interim report Q1'25

8.5.

2025

General meeting '25

19.8.

2025

Interim report Q2'25

All

Webcasts

Press releases

ShowingAll content types

Regulatory press release1 hour ago

Clarification to the previous proposal regarding authorization in the notice to the Annual General Meeting of BICO Group AB (publ)

Press release4/16/2025, 5:00 AM

Invitation to the presentation of BICO’s Interim report Q1 2025

Regulatory press release4/15/2025, 5:00 AM

Correction: Notice to attend Annual General Meeting in BICO Group AB (publ)

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release4/7/2025, 5:00 AM

Notice to attend Annual General Meeting in BICO Group AB (publ)

Regulatory press release4/4/2025, 4:00 PM

BICO has entered into an agreement to divest MatTek to Sartorius for USD 80m

BICO, Audiocast with teleconference, Q1'25

Webcast4/29/2025, 8:00 AM

BICO, Audiocast with teleconference, Q1'25

Regulatory press release3/20/2025, 8:00 AM

BICO Publishes Annual and Sustainability Report 2024

BICO, Audiocast with teleconference, Q4'24

Webcast2/19/2025, 9:00 AM

BICO, Audiocast with teleconference, Q4'24

Regulatory press release2/19/2025, 6:00 AM

Publication of BICO Group AB: Year-end report 2024

Regulatory press release2/18/2025, 4:42 PM

BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 276m

Press release2/5/2025, 6:00 AM

Invitation to the presentation of BICO’s Year-end report 2024

Press release11/28/2024, 10:40 AM

BICO completes the divestment of Nanoscribe

BICO, Audiocast with teleconference, Q3'24

Webcast11/26/2024, 9:00 AM

BICO, Audiocast with teleconference, Q3'24

Regulatory press release11/26/2024, 6:00 AM

Publication of BICO Group Interim Report January-September 2024

Press release11/25/2024, 6:00 PM

CELLINK announces further right-sizing and launches sharpened commercial agenda

Press release11/22/2024, 5:00 PM

BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 118m

Regulatory press release11/21/2024, 4:50 PM

BICO has entered into an agreement to divest Nanoscribe

Press release11/5/2024, 6:00 AM

Invitation to the presentation of BICO’s interim report Q3, 2024

Regulatory press release10/18/2024, 5:00 AM

BICO’s Calendar for financial reporting: H2 2024 and 2025

Regulatory press release10/9/2024, 5:00 AM

BICO Group AB’s Nomination Committee for the 2025 Annual General Meeting

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.